Connection

Gary Gilkeson to Immunoglobulin G

This is a "connection" page, showing publications Gary Gilkeson has written about Immunoglobulin G.
Connection Strength

0.837
  1. Novel mechanism for estrogen receptor alpha modulation of murine lupus. J Autoimmun. 2019 02; 97:59-69.
    View in: PubMed
    Score: 0.132
  2. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus. J Immunol. 2006 Nov 15; 177(10):7423-34.
    View in: PubMed
    Score: 0.057
  3. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice. Eur J Immunol. 2006 May; 36(5):1296-308.
    View in: PubMed
    Score: 0.055
  4. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J Immunol. 2004 Nov 15; 173(10):6481-9.
    View in: PubMed
    Score: 0.050
  5. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int. 2004 Jan; 65(1):129-38.
    View in: PubMed
    Score: 0.047
  6. Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice. Clin Immunol. 2003 Jun; 107(3):186-97.
    View in: PubMed
    Score: 0.045
  7. Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus. J Autoimmun. 2022 07; 131:102860.
    View in: PubMed
    Score: 0.043
  8. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J Immunol. 2001 May 15; 166(10):6444-51.
    View in: PubMed
    Score: 0.039
  9. Effect of a genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production by C57BL6 Fas(lpr) mice. Clin Immunol. 2000 Jan; 94(1):24-32.
    View in: PubMed
    Score: 0.036
  10. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians. 1999 Nov-Dec; 111(6):611-21.
    View in: PubMed
    Score: 0.035
  11. Soluble CD16 in the treatment of murine lupus nephritis. Clin Immunol Immunopathol. 1998 Jul; 88(1):91-5.
    View in: PubMed
    Score: 0.032
  12. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med. 1996 Apr 01; 183(4):1389-97.
    View in: PubMed
    Score: 0.028
  13. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. PLoS One. 2013; 8(8):e69404.
    View in: PubMed
    Score: 0.023
  14. The fine specificity of monoclonal anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. J Autoimmun. 1993 Feb; 6(1):11-26.
    View in: PubMed
    Score: 0.022
  15. Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice. Clin Immunol Immunopathol. 1992 Aug; 64(2):166-72.
    View in: PubMed
    Score: 0.021
  16. Patterns of heavy and light chain utilization in the antibody response to single-stranded bacterial DNA in normal human subjects and patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1992 Jan; 62(1 Pt 1):25-32.
    View in: PubMed
    Score: 0.021
  17. Genetic control of inflammatory arthritis and glomerulonephritis in congenic lpr mice and their F1 hybrids. J Autoimmun. 1991 Aug; 4(4):595-606.
    View in: PubMed
    Score: 0.020
  18. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice. Arthritis Rheum. 2011 Apr; 63(4):1076-85.
    View in: PubMed
    Score: 0.019
  19. Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice. Clin Exp Immunol. 2010 Nov; 162(2):362-71.
    View in: PubMed
    Score: 0.019
  20. The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice. J Immunol. 2008 Aug 01; 181(3):1644-54.
    View in: PubMed
    Score: 0.016
  21. Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur J Immunol. 2007 Jun; 37(6):1691-701.
    View in: PubMed
    Score: 0.015
  22. Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci U S A. 2007 Apr 24; 104(17):7193-8.
    View in: PubMed
    Score: 0.015
  23. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. Am J Pathol. 2007 Apr; 170(4):1258-66.
    View in: PubMed
    Score: 0.015
  24. Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice. J Immunol. 2005 Apr 15; 174(8):5065-73.
    View in: PubMed
    Score: 0.013
  25. Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus. Genes Immun. 2003 Dec; 4(8):575-85.
    View in: PubMed
    Score: 0.012
  26. Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop Relat Res. 1997 Dec; (345):174-80.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.